ReviewEndocrine, metabolic & immune disorders drug targets2026
Falsely Elevated Estradiol Levels Due to Heterophile Antibody Interference: A Case Report and Literature Review
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmunoassay interference remains an important issue in clinical laboratory medicine, and false increases in estradiol levels due to detection interference are rare, but they cannot be ignored. CASE PRESENTATION: We herein report the case of a 41-year-old woman who underwent a series of extensive and superfluous medical examinations because of erroneous laboratory findings according to the Siemens Centaur serum estradiol assay due to heterophile antibody interference. Her estradiol levels were measured several times, which measured between 7534 and 9772 pg/mL. Heterophile antibody interference was identified through method comparisons, polyethylene glycol precipitation, a gradient dilution test, and the use of a heterophile-blocking reagent.
conclusionThe rapid identification of interference in estradiol testing poses a challenge for laboratory staff; however, it is vital for preventing unnecessary medical treatment and reducing healthcare costs. Analytical interference should be suspected when clinical manifestations do not align with laboratory results. Consequently, clinicians and laboratory personnel need to develop an anti- interference workflow to mitigate such occurrences in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.